{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:12:30Z","timestamp":1780362750447,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,29]]},"DOI":"10.7759\/cureus.10112","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T15:12:22Z","timestamp":1598713942000},"source":"Crossref","is-referenced-by-count":4,"title":["Primary Periodic Paralyses: A Review of Etiologies and Their Pathogeneses"],"prefix":"10.7759","author":[{"given":"Umar","family":"Farooque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asfand Yar","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2007.00963.x","article-title":"Primary periodic paralyses","volume":"117","author":"Finsterer J","year":"2008","unstructured":"Finsterer J. Primary periodic paralyses. Acta Neurol Scand. 2008, 117:145-158. 10.1111\/j.1600-0404.2007.00963.x","journal-title":"Acta Neurol Scand"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3921","article-title":"Clinical and etiological spectrum of hypokalemic periodic paralysis in a tertiary care hospital in Pakistan","volume":"11","author":"Sardar Z","year":"2019","unstructured":"Sardar Z, Waheed KAF, Javed MA, Akhtar F, Bokhari SRA. Clinical and etiological spectrum of hypokalemic periodic paralysis in a tertiary care hospital in Pakistan. Cureus. 2019, 11:e3921. 10.7759\/cureus.3921","journal-title":"Cureus"},{"key":"ref3","article-title":"Hyperkalemic Periodic Paralysis","author":"Weber F","year":"2003","unstructured":"Weber F, Jurkat-Rott K, Lehmann-Horn F. Hyperkalemic Periodic Paralysis. Adam MP, Ardinger HH, Pagon RA, et al. (ed): GeneReview, University of Washington, Seattle, WA; 2003-2016."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1999.00321.x","article-title":"Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L\u2010type Ca2+ channel expressed in xenopus laevis oocytes","volume":"520","author":"Morrill JA","year":"1999","unstructured":"Morrill JA, Cannon SC. Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L\u2010type Ca2+ channel expressed in xenopus laevis oocytes. J Physiol. 1999, 520:321-336. 10.1111\/j.1469-7793.1999.00321.x","journal-title":"J Physiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2007.01.012","article-title":"The nondystrophic myotonias","volume":"4","author":"Heatwole CR","year":"2007","unstructured":"Heatwole CR, Moxley RT 3rd. The nondystrophic myotonias. Neurotherapeutics. 2007, 4:238-251. 10.1016\/j.nurt.2007.01.012","journal-title":"Neurotherapeutics"},{"key":"ref6","article-title":"Hypokalemic Periodic Paralysis","author":"Weber F","year":"2002","unstructured":"Weber F, Lehmann-Horn F. Hypokalemic Periodic Paralysis. Adam MP, Ardinger HH, Pagon RA, et al. (ed): GeneReview, University of Washington, Seattle, WA; 2002-2018."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2007.02.001","article-title":"Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis","volume":"4","author":"Jurkat\u2010Rott K","year":"2007","unstructured":"Jurkat\u2010Rott K, Lehmann\u2010Horn F. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis. Neurotherapeutics. 2007, 4:216-224. 10.1016\/j.nurt.2007.02.001","journal-title":"Neurotherapeutics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani\u2010Firouzi M","year":"2002","unstructured":"Tristani\u2010Firouzi M, Jensen JL, Donaldson MR, et al.. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest. 2002, 110:381-388. 10.1172\/JCI15183","journal-title":"J Clin Invest"},{"key":"ref9","article-title":"Heredit\u00e4re Ionenkanalerkrankungen des peripheren nervensystems. (Article in German)","volume":"4","author":"Finsterer J","year":"2003","unstructured":"Finsterer J. Heredit\u00e4re Ionenkanalerkrankungen des peripheren nervensystems. (Article in German). J Neurol Neurochir Psychiatr. 2003, 4:7-14.","journal-title":"J Neurol Neurochir Psychiatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2004.081620","article-title":"In vivo and in vitro functional characterization of Andersen\u2019s syndrome mutations","volume":"565","author":"Bendahhou S","year":"2005","unstructured":"Bendahhou S, Fournier E, Sternberg D, et al.. In vivo and in vitro functional characterization of Andersen\u2019s syndrome mutations. J Physiol. 2005, 565:731-741. 10.1113\/jphysiol.2004.081620","journal-title":"J Physiol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.102609499","article-title":"Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen\u2019s syndrome","volume":"99","author":"Preisig\u2010Muller R","year":"2002","unstructured":"Preisig\u2010Muller R, Schlichthorl G, Goerge T, et al.. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen\u2019s syndrome. Proc Natl Acad Sci USA. 2002, 99:7774-7779.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref12","article-title":"Congenital Myasthenic Syndromes","author":"Abicht A","year":"2003","unstructured":"Abicht A, M\u00fcller J, Lochm\u00fcller H. Congenital Myasthenic Syndromes. Pagon RA, Adam MP, Ardinger HH, et al. (ed): GeneReview, University of Washington, Seattle, WA; 2003-2016."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1230273100","article-title":"Myasthenic syndrome caused by mutation of the SCN4A sodium channel","volume":"100","author":"Tsujino A","year":"2003","unstructured":"Tsujino A, Maertens C, Ohno K, et al.. Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc Natl Acad Sci USA. 2003, 100:7377-7382. 10.1073\/pnas.1230273100","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39068-primary-periodic-paralyses-a-review-of-etiologies-and-their-pathogeneses","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:35Z","timestamp":1707506495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39068-primary-periodic-paralyses-a-review-of-etiologies-and-their-pathogeneses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,29]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.10112","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,29]]}}}